Citations

Clear

6273 citation(s) found for "To, Andrew".

OC-030 Effective Stratification Of Hepatocellular Carcinoma Risk In Primary Biliary Cirrhosis: Results Of A Multi-centre International Study
Trivedi, PJ, Buuren, H. van, Battezzati, Pm, Floreani, Annarosa , Ponsioen, Cyriel Y. , Poupon, R., Mayo, Marlyn J. , Talwalkar, Jayant A., Burroughs, AK, Nevens, Frederik , Bruns, Tony , Li, KK, Cheung, Angela , Cazagon, N, Franceschet, I., Imam, Mohamad , Pieri, Giulia , Kanwar, Pushpjeet, Lindor, Keith D. , Lammers, Willem J. , Janssen, Harry L.A. , Invernizzi, Pietro , Parés, Albert , Corpechot, Christophe , Mason, Andrew L. , Kowdley, Kris V. , Kumagi, Teru , Lleò, Ana , Caballería, Llorenç , Boonstra, Kirsten , Vries, Esther de , Hansen, Bettina E. , Hirschfield, Gideon M. , Bruns, Tony

Mayo Clinic

Gut | June 9, 2014 | Volume: 63 | Issue: Suppl 1 | Pages: A15-A16

10.1136/gutjnl-2014-307263.30 Get It

Introduction Hepatocellular carcinoma (HCC) is an important but infrequent outcome in primary biliary cirrhosis (PBC). Improved risk evaluation is an important goal for stratified surveillance. Methods Risk-factor analysis of the ‘Global PBC Study Group’ comprising 15 centres across North America and Europe spanning >40-years follow-up was performed using Cox proportional hazards model, logistic regression and Kaplan-Meier estimates (SPSSv21). Results Of 3546 patients with PBC (med. follow-up 8.6 yrs; IQR 4.4–14.1), 131 developed HCC. Excluding those who developed HCC within 12 months of PBC diagnosis (n = 23), median time to HCC was 12.7 yrs (6.9–16.8) and subsequent survival 1.1 yrs. (0.2–2.7). At diagnosis, factors associated with HCC development were male gender (adj. HR: 4.4;1.4–12.2, p = 0.014) and thrombocytopenia (adj. HR: 4.5;1.4–14.8, p = 0.012). Use of ursodeoxycholic acid per-se was not associated with future risk of HCC, but stratification of risk by biochemical response at 12 months was effective by Rotterdam (adj. HR: 8.9;2.1–37.3, P = 0.003), Paris-I (adj. HR: 7.6;2.0–29.0, p = 0.003) or Toronto criteria (HR: 5.6;1.6–18.8, P = 0.006). Five (4.6 vs. 0.2%) and 10-year (13%vs.1.9%) HCC incidence was significantly increased for biochemical non-responders (p = 2.2 × 10 –9 ), and by multivariate analysis non-response remained the only significant risk factor. Conclusion Our uniquely powered cohort allows robust demonstration that 12-month biochemical non-response is associated with an increased risk of developing HCC in PBC. Routine surveillance in those achieving biochemical response is unlikely cost-effective. Disclosure of Interest None Declared.
Transvenous Stimulation of the Renal Sympathetic Nerves Increases Systemic Blood Pressure: A Potential New Treatment Option for Neurocardiogenic Syncope
Madhavan, Malini , Ebrille, Elisa , Mulpuru, Siva K. , Mikell, Susan B. , Johnson, Susan B., Suddendorf, Scott H., Ladewig, Dorothy J., Gilles, Emily J., Danielsen, Andrew J., Asirvatham, Samuel J. , DeSimone, Christopher V. , Asirvatham, Samuel J

Mayo Clinic

Journal of Cardiovascular Electrophysiology | June 5, 2014 | Volume: 25 | Issue: 10 | Pages: 1115-1118

10.1111/jce.12466 | PMID 24902981 Get It

Renal Vein Stimulation Increases Blood PressureBackgroundNeurocardiogenic syncope (NCS) is a common and sometimes debilitating disorder, with no consistently effective treatment. NCS is due to a combination of bradycardia and vasodilation leading to syncope. Although pacemaker devices have been tried in treating the bradycardic aspect of NCS, no device‐based therapy exists to treat the coexistent vasodilation that occurs. The renal sympathetic innervation has been the target of denervation to treat hypertension. We hypothesized that stimulation of the renal sympathetic nerves can increase blood pressure and counteract vasodilation in NCS.Methods and ResultsHigh‐frequency stimulation (800–900 pps, 10 V, 30–200 seconds) was performed using a quadripolar catheter in the renal vein of 7 dogs and 1 baboon. A significant increase in blood pressure (BP; mean [SD] systolic BP 117 [±28] vs. 128 [±33], diastolic BP 75 [±19] vs. 87 [±29] mmHg) was noted during the stimulation, which returned to baseline after cessation of stimulation. The mean increase in systolic and diastolic BP was 13.0 (±3.3) (P = 0.006) and 10.2 (±4.6) (P = 0.08), respectively.ConclusionWe report the first ever study of feasibility and safety of high‐frequency electrical stimulation of the renal sympathetic innervation to increase BP in animal models. This has potential applications in the treatment of hypotensive states such as NCS.
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
Castellar, Edgardo R. Parrilla , Jaffe, Elaine S. , Said, Jonathan , Ketterling, Rhett P. , Knudson, Ryan A., Sidhu, Jagmohan S. , Karikehalli, Shridevi, Jiang, Liuyan , Vasmatzis, George , Ondrejka, Sarah L. , Nicolae, Alina , Grogg, Karen L., Allmer, Cristine, Ristow, Kay M., Wilson, Wyndham H. , Macon, William R. , Cerhan, James R. , Ansell, Stephen M. , Maurer, Matthew J. , Feldman, Andrew L. , Parrilla Castellar, Edgardo R, Law, Mark E. , Doǧan, Ahmet , Feldman, Andrew L , Swerdlow, Steven H. , Hsi, Eric D. , Gibson, Sarah E. , Habermann, Thomas M. , Maurer, Matthew , Cerhan, James R , Jaffe, Elaine S , Ketterling, Rhett P

Mayo Clinic

Blood | June 3, 2014 | Volume: 124 | Issue: 9 | Pages: 1473-1480

10.1182/blood-2014-04-571091 | PMID 24894770 Get It

Key Points ALK-negative ALCLs have chromosomal rearrangements of DUSP22 or TP63 in 30% and 8% of cases, respectively. DUSP22-rearranged cases have favorable outcomes similar to ALK-positive ALCLs, whereas other genetic subtypes have inferior outcomes.
Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents
Daher, João Paulo Lima , Moehle, Mark S. , Hinkle, Kelly M., Melrose, Heather L. , West, Andrew B. , Cowell, Rita M. , Standaert, David G. , Volpicelli‐Daley, Laura A.

Mayo Clinic

Journal of Comparative Neurology | June 2, 2014 | Volume: 522 | Issue: 11 | Pages: No page available

10.1002/cne.23612 Get It

ABSTRACTMutations in leucine‐rich repeat kinase 2 (LRRK2) are found in a significant proportion of late‐onset Parkinson's disease (PD) patients. Elucidating the neuroanatomical localization of LRRK2 will further define LRRK2 function and the molecular basis of PD. Here, we utilize recently characterized monoclonal antibodies to evaluate LRRK2 expression in rodent brain regions relevant to PD. In both mice and rats, LRRK2 is highly expressed in the cortex and striatum, particularly in pyramidal neurons of layer V and in medium spiny neurons within striosomes. Overall, rats have a more restricted distribution of LRRK2 compared with mice. Mice, but not rats, show high levels of LRRK2 expression in the substantia nigra pars compacta. Expression of the pathogenic LRRK2‐G2019S protein from mouse bacterial artificial chromosome (BAC) constructs closely mimics endogenous LRRK2 distribution in the mouse brain. However, LRRK2‐G2019S expression derived from human BAC constructs causes LRRK2 to be expressed in additional neuron subtypes in the rat such as striatal cholinergic interneurons and the substantia nigra pars compacta. The distribution of LRRK2 from human BAC constructs more closely resembles descriptions of LRRK2 in humans and nonhuman primates. Computational analyses of DNA regulatory elements in LRRK2 show a primate‐specific promoter sequence that does not exist in lower mammalian species. These noncoding regions may be involved in directing neuronal expression patterns. Together, these studies will aid in understanding the normal function of LRRK2 in the brain and will assist in model selection for future studies. J. Comp. Neurol. 522:2465–2480, 2014. © 2014 Wiley Periodicals, Inc.
Adenine Nucleotide Translocase Is Acetylated in Vivo in Human Muscle: Modeling Predicts a Decreased ADP Affinity and Altered Control of Oxidative Phosphorylation
Mielke, Clinton, Lefort, Natalie , McLean, Carrie G., Cordova, Jeanine M., Langlais, Paul R. , Bordner, Andrew J., Te, Jerez A., Willis, Wayne T. , Mandarino, Lawrence J. , Ozkan, S. Banu

Mayo Clinic

Biochemistry | June 2, 2014 | Volume: 53 | Issue: 23 | Pages: 3817-3829

10.1021/bi401651e | PMID 24884163 Get It

An investigation into false‐negative transthoracic fine needle aspiration and core biopsy specimens
Minot, Douglas M., Gilman, Elizabeth A. , Aubry, Marie‐Christine, Voss, Jesse S. , Epps, Sarah G. Van, Tuve, Delores J, Sciallis, Andrew P. , Henry, Michael , Salomão, Diva R. , Carlson, Stephanie K., Clayton, Amy C., Aubry, Marie-Christine, Lee, Peter

Mayo Clinic

Diagnostic Cytopathology | May 28, 2014 | Volume: 42 | Issue: 12 | Pages: 1063-1068

10.1002/dc.23169 | PMID 24866385 Get It

Transthoracic fine needle aspiration (TFNA)/core needle biopsy (CNB) under computed tomography (CT) guidance has proved useful in the assessment of pulmonary nodules. We sought to determine the TFNA false‐negative (FN) rate at our institution and identify potential causes of FN diagnoses. Medical records were reviewed from 1,043 consecutive patients who underwent CT‐guided TFNA with or without CNB of lung nodules over a 5‐year time period (2003–2007). Thirty‐seven FN cases of “negative” TFNA/CNB with malignant outcome were identified with 36 cases available for review, of which 35 had a corresponding CNB. Cases were reviewed independently (blinded to original diagnosis) by three pathologists with 15 age‐ and sex‐matched positive and negative controls. Diagnosis (i.e., nondiagnostic, negative or positive for malignancy, atypical or suspicious) and qualitative assessments were recorded. Consensus diagnosis was suspicious or positive in 10 (28%) of 36 TFNA cases and suspicious in 1 (3%) of 35 CNB cases, indicating potential interpretive errors. Of the 11 interpretive errors (including both suspicious and positive cases), 8 were adenocarcinomas, 1 squamous cell carcinoma, 1 metastatic renal cell carcinoma, and 1 lymphoma. The remaining 25 FN cases (69.4%) were considered sampling errors and consisted of 7 adenocarcinomas, 3 nonsmall cell carcinomas, 3 lymphomas, 2 squamous cell carcinomas, and 2 renal cell carcinomas. Interpretive and sampling error cases were more likely to abut the pleura, while histopathologically, they tended to be necrotic and air‐dried. The overall FN rate in this patient cohort is 3.5% (1.1% interpretive and 2.4% sampling errors). Diagn. Cytopathol. 2014;42:1063–1068;. © 2014 Wiley Periodicals, Inc.
Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia
Claus, Rainer , Lucas, David , Ruppert, Amy S. , Williams, Katie , Weng, Daniel , Patterson, Kara, Zucknick, Manuela , Oakes, Christopher C. , Rassenti, Laura Z., Greaves, Andrew, Geyer, Susan M. , Brown, Jennifer R. , Barrientos, Jacqueline C. , Rai, Kanti R., Shields, Peter G. , Zhao, Weiqiang , Grever, Michael R. , Plass, Christoph , Byrd, John C. , Byrd, John C. , Wierda, William G. , Gribben, John G. , Rai, Kanti R., Kay, Neil E. , Kipps, Thomas J. , Barrientos, Jacqueline , Byrd, John C

Mayo Clinic

Blood | May 28, 2014 | Volume: 124 | Issue: 1 | Pages: 42-48

10.1182/blood-2014-02-555722 | PMID 24868078 Get It

Key Points Methylation analysis at ZAP-70 CpG+223 in CLL provides superior prognostic information vs IGHV status or CD38 or ZAP-70 expression. A pyrosequencing method for the feasible assessment of CpG+223 methylation in CLL samples is provided.
AQP4 autoantibody assay performance in clinical laboratory service
Fryer, J.P. , Lennon, Vanda A. , Pittock, Sean J. , Jenkins, Sarah M. , Fallier‐Becker, Petra, Clardy, Stacey , Horta, Erika , Jedynak, E.A., Lucchinetti, Claudia F. , Shuster, Elizabeth A., Weinshenker, Brian G. , Wingerchuk, Dean M. , McKeon, Andrew , Pittock, S J , Weinshenker, Brian G , McKeon, Andrew , Clardy, Stacey L

Mayo Clinic

Neurology Neuroimmunology & Neuroinflammation | May 23, 2014 | Volume: 1 | Issue: 1 | Pages: No page available

10.1212/nxi.0000000000000011 | PMID 25340055 Get It

Disclosure of Funding Sources and Conflicts of Interest in Phase III Surgical Trials: Survey of 10 General Surgery Journals
Sarr, Michael G. , Warshaw, Andrew L.

Mayo Clinic

World Journal of Surgery | May 22, 2014 | Volume: 38 | Issue: 10 | Pages: 2494-2494

10.1007/s00268-014-2648-2 Get It

Comparison of Cellular Architecture, Axonal Growth, and Blood Vessel Formation Through Cell-Loaded Polymer Scaffolds in the Transected Rat Spinal Cord
Madigan, Nicolas N. , Chen, Bingkun K. , Rooney, Gemma E., Sweeney, Eva , Kinnavane, Lisa , Yaszemski, Michael J. , Dockery, Peter , McMahon, Siobhán S. , Windebank, Anthony J. , Knight, Andrew Michael , O’Brien, Timothy

Mayo Clinic

Tissue Engineering Part A | May 22, 2014 | Volume: 20 | Issue: 21-22 | Pages: 2985-2997

10.1089/ten.tea.2013.0551 | PMID 24854680 Get It